The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to efficiently develop and test novel TB vaccine candidates. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect a BCG vac...
Hlavní autoři: | Brennan, M, Tanner, R, Morris, S, Scriba, T, Achkar, J, Zelmer, A, Hokey, D, Izzo, A, Sharpe, S, Williams, A, Penn-Nicholson, A, Erasmus, M, Stylianou, E, Hoft, D, McShane, H, Fletcher, H |
---|---|
Médium: | Journal article |
Vydáno: |
American Society for Microbiology
2017
|
Podobné jednotky
-
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
Autor: Tanner, R, a další
Vydáno: (2021) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
Autor: Pepponi, I, a další
Vydáno: (2017) -
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
Autor: McShane, H, a další
Vydáno: (2016) -
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
Autor: Painter, H, a další
Vydáno: (2024) -
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
Autor: Tanner, R, a další
Vydáno: (2021)